CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $20,595,000 | +2393.3% | 1,954,019 | +5863.7% | 1.56% | +2194.1% |
| Q2 2015 | $826,000 | -94.6% | 32,765 | -94.0% | 0.07% | -95.0% |
| Q1 2015 | $15,245,000 | +3102.7% | 547,000 | +1995.8% | 1.37% | +2532.7% |
| Q4 2014 | $476,000 | -96.9% | 26,100 | -97.0% | 0.05% | -97.1% |
| Q1 2014 | $15,266,000 | +58.5% | 863,947 | +117.1% | 1.82% | +53.3% |
| Q4 2013 | $9,634,000 | – | 397,951 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |